Skip to main content

Specific Orbital Inflammatory Diseases

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology
  • 466 Accesses

Abstract

Several specific inflammatory diseases may affect the orbit either in isolation or as part of a systemic disease process. Many of these will present with tumefactive lesions that may mimic neoplasia. The classic features of inflammation such as redness, swelling, pain, and loss of function may be absent, which may also lead to the impression of neoplasia. The conditions covered in this chapter include the granulomatous diseases sarcoidosis and the xanthogranulomatous processes, Sjögren’s syndrome, the vasculitic diseases granulomatosis with polyangiitis (GPA or Wegener’s granulomatosis) and eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), and the recently recognized entity of IgG4-related disease. Sjögren’s syndrome and IgG4-related disease also carry an increased risk of the development of lymphoma, as occurs in many other chronic inflammatory diseases. The disease processes in this chapter have specific clinicopathological features, and their systemic manifestations may have significant impacts on the well-being of the patient, and establishing a diagnosis is of importance. A tissue biopsy is nearly always needed to establish a diagnosis, but additional serological tests may also be helpful.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Prabhakaran VC, Saeed P, Esmaeli B, et al. Orbital and adnexal sarcoidosis. Arch Ophthalmol. 2007;125:1657–62.

    PubMed  Google Scholar 

  2. Mavrikakis I, Rootman J. Diverse clinical presentations of orbital sarcoid. Am J Ophthalmol. 2007;144:760–75.

    Google Scholar 

  3. Demirci H, Christianson MD. Orbital and adnexal involvement in sarcoidosis: analysis of clinical features and systemic disease in 30 cases. Am J Ophthalmol. 2011;151:1074–80.

    PubMed  Google Scholar 

  4. Sivak-Calcott JA, Rootman J, Rasmussen SL, et al. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006;90:602–8.

    Google Scholar 

  5. Satchi K, McNab AA, Godfrey T, et al. Adult orbital xanthogranuloma successfully treated with rituximab. Ophthalmology. 2014;121:1664–5.

    PubMed  Google Scholar 

  6. Sagiv O, Thakar SD, Morell G, et al. Rituximab monotherapy is effective in treating orbital necrobiotic xanthogranuloma. Ophthal Plast Reconstr Surg. 2018;34:e24–7.

    PubMed  Google Scholar 

  7. McKelvie P, McNab AA, Hardy TG, et al. Comparative study of clinical, pathological, radiological, and genetic features of patients with adult ocular adnexal xanthogranulomatous disease, Erdheim-Chester disease, and IgG4-related disease of the orbit/ocular adnexa. Ophthal Plast Reconstr Surg. 2017;33:112–9.

    PubMed  Google Scholar 

  8. Rischmueller M, Tieu J, Lester S. Primary Sjögren’s syndrome. Best Pract Res Clin Rheumatol. 2016;30:189–220.

    PubMed  Google Scholar 

  9. Parkin B, Chew JB, White VA, et al. Lymphocytic infiltration and enlargement of the lacrimal glands. A new subtype of primary Sjögren’s syndrome? Ophthalmology. 2005;112:2040–7.

    PubMed  Google Scholar 

  10. Liang Y, Yang Z, Qin B, Zhong R. Primary Sjögren’s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. 2014;73:1151–6.

    PubMed  Google Scholar 

  11. Tonami H, Matoba M, Yokata H, et al. Mucosa-associated lymphoid tissue lymphoma in Sjögren’s syndrome. Am J Roentgenol. 2002;179:485–9.

    Google Scholar 

  12. Cassidy DT, McKelvie P, Harris GJ, et al. Lacrimal gland orbital lobe cysts associated with MALT lymphoma and primary Sjögren’s syndrome. Orbit. 2005;24:257–63.

    PubMed  Google Scholar 

  13. Muller K, Lin JH. Orbital granulomatosis with polyangiitis (Wegener granulomatosis). Arch Pathol Lab Med. 2014;138:1110–4.

    PubMed  PubMed Central  Google Scholar 

  14. Harman LE, Margo CE. Wegener’s granulomatosis. Surv Ophthal. 1998;42:458–80.

    CAS  Google Scholar 

  15. Woo TL, Francis IC, Wilcsek GA. Australasian orbital and adnexal Wegener’s granulomatosis. Ophthalmology. 2001;108:1535–43.

    CAS  PubMed  Google Scholar 

  16. Tan LT, Davagnanam I, Isa H, et al. Clinical and imaging features of orbital granulomatosis with polyangiitis and the risk of systemic involvement. Ophthalmology. 2014;121:1304–9.

    PubMed  Google Scholar 

  17. Tan LT, Davagnanam I, Isa H, et al. Clinical and imaging features of lacrimal gland involvement in granulomatosis with polyangiitis. Ophthalmology. 2015;122:2125–9.

    PubMed  Google Scholar 

  18. Lee BJ, Nelson CC, Lewis CD, et al. External dacryocystorhinostomy in patients with Wegener granulomatosis. Ophthal Plast Reconstr Surg. 2012;28:389–92.

    PubMed  Google Scholar 

  19. Rosenbaum JT, Choi D, Wilson DJ, et al. Orbital pseudotumor can be a localized form of granulomatosis with polyangiitis as revealed by gene expression profiling. Exp Mol Pathol. 2015;99:271–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Pakrou N, Selva D, Leibovitch I. Wegener’s granulomatosis: ophthalmic manifestations and management. Semin Arthritis Rheum. 2006;35:284–92.

    PubMed  Google Scholar 

  21. Taylor SR, Salama AD, Joshi L, et al. Rituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosis. Arthritis Rheum. 2009;60:1540–7.

    PubMed  Google Scholar 

  22. McNab AA. Orbital inflammation in Churg-Strauss syndrome. Orbit. 1998;17:203–5.

    PubMed  Google Scholar 

  23. Heine A, Beck R, Stropahi G, et al. Inflammatory pseudotumour of the anterior orbit. A symptom in allergic granulomatous angiitis (Churg-Strauss syndrome). Ophthalmologe. 1995;92:870–3.

    CAS  PubMed  Google Scholar 

  24. Pradeep TG, Prabhakaran VC, McNab A, et al. Diffuse orbital inflammation in Churg-Strauss syndrome. Ophthal Plast Reconstr Surg. 2010;26:57–9.

    PubMed  Google Scholar 

  25. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.

    CAS  PubMed  Google Scholar 

  26. Deshpande V, Zen Y, Chan JKC, et al. Consensus statement on the pathology of IgG4-related disease. Hum Pathol. 2012;25:1181–92.

    Google Scholar 

  27. Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21–30.

    CAS  PubMed  Google Scholar 

  28. Goto H, Takahira M, Azumi A, Japanese Study Group for IgG4-Related Ophthalmic Disease. Diagnostic criteria for IgG4-related ophthalmic disease. Jpn J Ophthalmol. 2015;59:1–7.

    CAS  PubMed  Google Scholar 

  29. Chang SY, Keogh KA, Lewis JE, et al. IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathological and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol. 2013;44:2432–7.

    CAS  PubMed  Google Scholar 

  30. McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part I: background and pathology. Ophthal Plast Reconstr Surg. 2015;31:83–8.

    PubMed  Google Scholar 

  31. McNab AA, McKelvie P. IgG4-related ophthalmic disease. Part II: clinical aspects. Ophthal Plast Reconstr Surg. 2015;31:167–78.

    PubMed  Google Scholar 

  32. Aziz HA, Villa-Forte A, Plesec TP, et al. Isolated conjunctival inflammation suggestive of IgG4-related disease. Ocul Oncol Pathol. 2015;2:51–3.

    PubMed  PubMed Central  Google Scholar 

  33. Watanabe T, Fujinaga Y, Kawakami S, et al. Infraorbital nerve swelling associated with autoimmune pancreatitis. Jpn J Radiol. 2011;29:194–201.

    PubMed  Google Scholar 

  34. Hardy TG, McNab AA, Rose GE. Enlargement of the infraorbital nerve: an important sign associated with orbital reactive lymphoid hyperplasia or IgG4-related inflammation. Ophthalmology. 2014;121:1297–303.

    PubMed  Google Scholar 

  35. Cheuk W, Yuen HKL, Chan ACL, et al. Ocular adnexal lymphoma associated with IgG4+ chronic sclerosing dacryoadenitis: a previously undescribed complication of IgG4-related sclerosing disease. Am J Surg Pathol. 2008;32:1159–67.

    PubMed  Google Scholar 

  36. Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190–5.

    CAS  PubMed  Google Scholar 

  37. Ebbo M, Grados A, Guedj E, et al. Usefulness of 2-[18F]-flouro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken). 2014;66:86–96.

    CAS  Google Scholar 

  38. Khosroshahi A, Bloch DB, Deshpande V, et al. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755–62.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

McNab, A.A. (2019). Specific Orbital Inflammatory Diseases. In: Hwang, C.J., Patel, B.C., Singh, A.D. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-13558-4_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13558-4_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13557-7

  • Online ISBN: 978-3-030-13558-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics